Investors

OraSure Technologies develops, manufactures and markets oral fluid specimen collection devices using proprietary oral fluid technologies, diagnostic products including immunoassays and other in vitro diagnostic tests, and other medical devices. These products are sold in the United States as well as internationally to various clinical laboratories, hospitals, clinics, community-based organizations and other public health organizations, distributors, government agencies, physicians’ offices, and commercial and industrial entities.
More>>
Featured Reports
2017 Annual Report on Form 10-K - PDF 2017 Annual Report on Form 10-K
Fact Sheet - PDF Fact Sheet
OSUR (Common Stock)
ExchangeNASDAQ (US Dollar)
Price$11.51
Change (%)0.00 (0.00%)
Volume0
Data as of 12/17/18 4:00 p.m. ET
Minimum 20 minute delay
Refresh quote
Recent NewsMore >>
DateTitle 
12/10/18OraSure Technologies Announces 2019 Annual Meeting Date
BETHLEHEM, Pa., Dec. 10, 2018 (GLOBE NEWSWIRE) -- OraSure Technologies, Inc. (NASDAQ: OSUR) today announced that its 2019 Annual Meeting of Stockholders is scheduled to be held at 10:00 a.m. EDT (7:00 a.m. PDT) on Tuesday, May 21, 2019.  This will be a completely virtual meeting, conducted as a live webcast.  Further details regarding the meeting will be provided at a later date. About OraSure Technologies OraSure Technologies is a leader in the development, manufacture and distribution of... 
Printer Friendly Version
11/29/18OraSure Technologies to Ring NASDAQ Stock Market Opening Bell in Honor of World AIDS Day
OraSure Working to End AIDS on a Global Scale BETHLEHEM, Pa., Nov. 29, 2018 (GLOBE NEWSWIRE) -- OraSure Technologies, Inc. (NASDAQ: OSUR), a leader in point of care diagnostic tests and specimen collection devices, today announced that Stephen S. Tang, Ph.D., President and CEO, will ring the NASDAQ stock market opening bell on Monday, December 3, 2018 in honor of World AIDS Day and the work OraSure is doing to end AIDS on a global scale. The bell ringing will take place at 9:15 am EST. “On... 
Printer Friendly Version
11/21/18OraSure Technologies to Present at the 30th Annual Piper Jaffray Healthcare Conference
BETHLEHEM, Pa., Nov. 21, 2018 (GLOBE NEWSWIRE) -- OraSure Technologies, Inc. (NASDAQ: OSUR), a leader in point of care diagnostic tests and specimen collection devices, today announced that Stephen S. Tang, Ph.D., President and CEO, will speak to the investment community at the 30TH Annual Piper Jaffray Healthcare Conference.  The conference will be simultaneously webcast over the Internet. Dr. Tang is scheduled to speak on November 28, 2018, at approximately 1:30 PM Eastern Time (10:30 AM ... 
Printer Friendly Version
11/08/18OraSure Technologies to Present at Canaccord Genuity Medical Technologies & Diagnostics Forum
BETHLEHEM, Pa., Nov. 08, 2018 (GLOBE NEWSWIRE) -- OraSure Technologies, Inc. (NASDAQ: OSUR), a leader in point of care diagnostic tests and specimen collection devices, today announced that Stephen S. Tang, Ph.D., President and CEO, will speak to the investment community at the Canaccord Genuity Medical Technologies & Diagnostics Forum.  The conference will be simultaneously webcast over the Internet. Dr. Tang is scheduled to speak on November 15, 2018, at approximately 1:00 PM Eastern Ti... 
Printer Friendly Version
Upcoming EventsMore >>
DateTitle
05/21/19 10:00 a.m. ET
OraSure Technologies, Inc. 2019 Annual Meeting of Stockholders
Data provided by Nasdaq. Minimum 15 minutes delayed. View Attributions and Sources



Print Page Print Page | E-mail Page E-mail Page | RSS Feeds RSS Feeds | E-mail Alerts E-mail Alerts | IR Contacts IR Contacts | Financial Tear Sheet Financial Tear Sheet